Indeed, it was recently reported that TGF‐β‐driven CD80 expression on tumor‐initiating stem cells promotes resistance to adoptive cell transfer (ACT) therapy via a CTLA‐4‐dependent mechanism.119. Here, TGFB1 is linked to neoplasm.